<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="27466">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02749162</url>
  </required_header>
  <id_info>
    <org_study_id>ID AN-001-14</org_study_id>
    <nct_id>NCT02749162</nct_id>
  </id_info>
  <brief_title>Perineural Dexamethasone in Femural Nerve Block After Ligament Reconstruction</brief_title>
  <official_title>Perineural Dexamethasone Administered in Femural Nerve Block After Anterior Cruciate Ligament Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Foisor Orthopedics Clinical Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Foisor Orthopedics Clinical Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of perineural dexamethasone administered as an adjuvant in prolonging the
      duration of analgesia continues to be under debate. The investigators performed a
      prospective randomized study to evaluate the effect of perineural dexamethasone in different
      concentrations in postoperative analgesia in femoral nerve block for anterior cruciate
      ligament reconstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After Ethics committee approval, 75 patients American Society of Anesthesiologists score
      (ASA) I-III were randomized at the end of surgery into 3 groups of 25 patients each who
      underwent femoral nerve block: group A with 20 ml ropivacaine 0,5% and 20 ml lidocaine 1%;
      group B with 20 ml ropivacaine 0,5%, 20 ml lidocaine 1% and 4 mg dexamethasone; group C with
      20 ml ropivacaine 0,5%, 20 ml lidocaine 1% and 8 mg dexamethasone.

      All groups received postoperative analgesia when visual analog scale (VAS) over 3 (by
      request), with IV Perfalgan 1 g and morphine (loading dose 0.1 mg/kg and titration until VAS
      under 3, followed by subcutaneous (SC) administration of 1/2 of total loading dose on demand
      for the following 24 hours (h) .

      Efficacy was evaluated by the time interval from performing the block until the first
      analgesic dose required, the total amount of morphine in the first 24 h postoperative, the
      patient satisfaction and the neurological side effects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the total amount of morphine</measure>
    <time_frame>At 24 hour postoperative</time_frame>
    <description>the morphine administered in milligrams</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the patient satisfaction</measure>
    <time_frame>At 24 hour postoperative</time_frame>
    <description>evaluation of satisfaction by a questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the number of patients with neurological motility side effects</measure>
    <time_frame>At 24 h postoperative</time_frame>
    <description>Following the postoperative motility of operated lower limb by Bromage scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of analgesia</measure>
    <time_frame>the first 24 hours</time_frame>
    <description>the time interval from performing the block until the first analgesic dose required at VAS &gt;3 (0 - no pain, 10 - the worst pain possible</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the number of patients with neurological sensibility side effects</measure>
    <time_frame>At 21 days postoperative</time_frame>
    <description>Following postoperative sensibility of operated lower limb by pinprick test</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After the spinal anesthesia regressed, the investigators performed a single shot femoral block with ropivacaine 0,5% 200 mg + lidocaine 1% 200 mg. After the block regression, at the first analgetic request the patients received the analgesia protocol was started for 24 h with paracetamol 1 g IV every 8 h and lornoxicam 8 mg PO every 12 h; if VAS was still over 3 after 30 min, morphine was given as a loading bolus of 0.1 mg/kg IV supplemented with 2 mg IV every 5 minutes until VAS &lt;3. After 2 h morphine was administered SC ½ of the total loading dose at request.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After the spinal anesthesia regressed, the investigators performed a single shot femural block with ropivacaine 0,5% 200 mg + lidocaine 1% 200 mg and 4 mg dexamethasone phosphate. After the block regression, at the first analgetic request the patients received the analgesia protocol was started for 24 h with paracetamol 1 g IV every 8 h and lornoxicam 8 mg PO every 12 h; if VAS was still over 3 after 30 min, morphine was given as a loading bolus of 0.1 mg/kg IV supplemented with 2 mg IV every 5 minutes until VAS &lt;3. After 2 h morphine was administered SC ½ of the total loading dose at request.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After the spinal anesthesia regressed, the investigators performed a single shot femural block with ropivacaine 0,5% 200 mg+ lidocaine 1% 200 mg and 8 mg dexamethasone phosphate.After the block regression, at the first analgetic request the patients received the analgesia protocol was started for 24 h with paracetamol 1 g IV every 8 h and lornoxicam 8 mg PO every 12 h; if VAS was still over 3 after 30 min, morphine was given as a loading bolus of 0.1 mg/kg IV supplemented with 2 mg IV every 5 minutes until VAS &lt;3. After 2 h morphine was administered SC ½ of the total loading dose at request.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone phosphate</intervention_name>
    <description>At the end of surgery the patients received single shot VIB block with the mixture according to the group allocation</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Decadron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>After the block regression, at the first analgetic request the patients received the analgesia protocol</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Perfalgan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>After the block regression, at the first analgetic request the patients received the analgesia protocol</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Morphine Sulfate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>At the end of surgery the patients received single shot VIB block with the mixture according to the group allocation</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>At the end of surgery the patients received single shot VIB block with the mixture according to the group allocation</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III

          -  BMI&lt;40

        Exclusion Criteria:

          -  High risk grade hypertension

          -  Chronic renal failure

          -  Known allergy to drugs used

          -  Chronic treatment with steroids

          -  Drugs dependency

          -  History of diabetes mellitus

          -  Ulcer or chronic gastritis

          -  Infection on the puncture site

          -  Neuropathy at the surgical level

          -  Coagulopathy

          -  Requesting another type of anesthesia

          -  Fear to sign informed consent

          -  By-pass aorto-femoral
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ioan Cristian Stoica, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Foisor Orthopedics Clinical Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ana Maria Munteanu, MD PhD</last_name>
    <phone>0040722514156</phone>
    <email>ammunteanu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arabela Cocea, MD PhD</last_name>
    <phone>0040744339150</phone>
    <email>anastasescu_arabela@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Foisor Orthopedics Clinical Hospital</name>
      <address>
        <city>Bucharest</city>
        <zip>021382</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Munteanu Ana-Maria, MD, PhD</last_name>
      <phone>+40212116348</phone>
      <email>ammunteanu@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Munteanu Ana-Maria, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florescu Cionac Simona, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anastase Denisa, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <results_reference>
    <citation>Huynh TM, Marret E, Bonnet F. Combination of dexamethasone and local anaesthetic solution in peripheral nerve blocks: A meta-analysis of randomised controlled trials. Eur J Anaesthesiol. 2015 Nov;32(11):751-8. doi: 10.1097/EJA.0000000000000248. Review.</citation>
    <PMID>25774458</PMID>
  </results_reference>
  <results_reference>
    <citation>Williams BA, Hough KA, Tsui BY, Ibinson JW, Gold MS, Gebhart GF. Neurotoxicity of adjuvants used in perineural anesthesia and analgesia in comparison with ropivacaine. Reg Anesth Pain Med. 2011 May-Jun;36(3):225-30. doi: 10.1097/AAP.0b013e3182176f70.</citation>
    <PMID>21519308</PMID>
  </results_reference>
  <results_reference>
    <citation>De Oliveira GS Jr, Castro Alves LJ, Nader A, Kendall MC, Rahangdale R, McCarthy RJ. Perineural dexamethasone to improve postoperative analgesia with peripheral nerve blocks: a meta-analysis of randomized controlled trials. Pain Res Treat. 2014;2014:179029. doi: 10.1155/2014/179029. Epub 2014 Nov 18. Review.</citation>
    <PMID>25485150</PMID>
  </results_reference>
  <results_reference>
    <citation>Brummett CM, Williams BA. Additives to local anesthetics for peripheral nerve blockade. Int Anesthesiol Clin. 2011 Fall;49(4):104-16. doi: 10.1097/AIA.0b013e31820e4a49. Review.</citation>
    <PMID>21956081</PMID>
  </results_reference>
  <results_reference>
    <citation>Williams BA, Schott NJ, Mangione MP, Ibinson JW. Perineural dexamethasone and multimodal perineural analgesia: how much is too much? Anesth Analg. 2014 May;118(5):912-4. doi: 10.1213/ANE.0000000000000203.</citation>
    <PMID>24781562</PMID>
  </results_reference>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 9, 2016</lastchanged_date>
  <firstreceived_date>February 22, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Foisor Orthopedics Clinical Hospital</investigator_affiliation>
    <investigator_full_name>Munteanu Ana Maria, MD, PhD</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
